Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance. Shafran SD, Hughes CA. HIV Med 2022 Aug 16. doi: 10.1111/hiv.13376.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shafran SD, Hughes CA. Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance. HIV Med 2022 Aug 16. doi: 10.1111/hiv.13376.
PMID: 35973753